A 58-year-old female with type 2 diabetes presents with symptoms of peripheral neuropathy, early diabetic retinopathy, and elevated blood pressure despite Lisinopril treatment. Her HbA1c is 8.5%, and her LDL cholesterol is 140 mg/dL. Given the initial assessment findings, which intervention should the nurse prioritize to address the patient's immediate needs and prevent further complications?

B) Start a GLP-1 receptor agonist to improve glycemic control and support weight management.

A) Increase the dose of Lisinopril to better control blood pressure.

B) Start a GLP-1 receptor agonist to improve glycemic control and support weight management.

C) Refer the patient to a dietitian for tailored dietary advice to manage blood glucose and cholesterol levels.

D) Educate the patient on daily foot inspection and refer to a podiatrist for foot care management.

A patient with diabetes presents with signs of peripheral neuropathy and early diabetic retinopathy. The patient's blood pressure remains elevated despite being on Lisinopril, and her lipid profile shows elevated LDL levels. Given these findings, which of the following interventions should the nurse prioritize to prevent the progression of diabetic complications?

B) Initiating a GLP-1 receptor agonist to improve glycemic control

A) Increasing the dose of Lisinopril to better control blood pressure

B) Initiating a GLP-1 receptor agonist to improve glycemic control

C) Educating the patient on lifestyle modifications such as diet and exercise

D) Referring the patient to an ophthalmologist for a comprehensive eye exam

A patient with type 2 diabetes mellitus and hypertension is experiencing improved glycemic control but continues to have elevated blood pressure and neuropathic pain. Which nursing intervention should be prioritized to address the patient's current symptoms and prevent further complications?

B) Encourage participation in a structured low-impact exercise program tailored to accommodate her neuropathic symptoms.

A) Educate the patient on the importance of adhering to her antihypertensive medication regimen.

B) Encourage participation in a structured low-impact exercise program tailored to accommodate her neuropathic symptoms.

C) Schedule frequent blood pressure monitoring to assess the effectiveness of the current antihypertensive strategy.

D) Emphasize the necessity of routine podiatric care to prevent diabetic foot complications.

A patient with type 2 diabetes and hypertension is experiencing improved glycemic control but persistent elevated blood pressure despite adherence to lifestyle modifications. The healthcare team considers adding a calcium channel blocker to her regimen. Which clinical reasoning supports this decision?

C) Calcium channel blockers are effective in reducing elevated blood pressure and may also provide renal protective effects in diabetic patients.

A) Calcium channel blockers are known to improve glycemic control, which will help further reduce her HbA1c levels.

B) The addition of a calcium channel blocker can help manage her neuropathic pain, thereby facilitating increased physical activity.

C) Calcium channel blockers are effective in reducing elevated blood pressure and may also provide renal protective effects in diabetic patients.

D) The addition of a calcium channel blocker can improve her lipid profile by reducing LDL cholesterol levels.

A patient with diabetes and newly diagnosed hypertension presents with increased fatigue, mild pitting edema, and trace proteinuria. Her serum creatinine is elevated. Which nursing intervention should be prioritized to prevent further renal damage?

B) Educate the patient on the importance of adhering to a low-sodium diet.

A) Encourage increased fluid intake to reduce serum creatinine levels.

B) Educate the patient on the importance of adhering to a low-sodium diet.

C) Suggest reducing protein intake to minimize proteinuria.

D) Recommend daily weight monitoring to assess fluid retention.

A patient with a history of diabetes presents with increased fatigue, mild lower extremity swelling, and elevated blood pressure. Lab results show a slight increase in serum creatinine and trace proteinuria. Which nursing intervention should be prioritized to address the potential onset of diabetic nephropathy?

B) Educate the patient on reducing sodium intake to manage hypertension.

A) Increase dietary protein intake to support kidney function.

B) Educate the patient on reducing sodium intake to manage hypertension.

C) Encourage increased fluid intake to promote renal clearance.

D) Suggest the use of over-the-counter diuretics to reduce edema.

A patient with hypertension and early diabetic nephropathy is being treated with lisinopril. Despite some improvement, her blood pressure remains elevated. What should the nurse prioritize to enhance the patient's treatment plan?

C) Reinforce the importance of lifestyle modifications and monitor adherence.

A) Increase the dose of lisinopril.

B) Add a calcium channel blocker to the medication regimen.

C) Reinforce the importance of lifestyle modifications and monitor adherence.

D) Schedule more frequent blood pressure monitoring visits.

A patient with hypertension and early diabetic nephropathy has been started on lisinopril. Despite some improvements, her blood pressure remains elevated at 148/92 mmHg. Which of the following nursing interventions would best address the patient's current condition while also considering her renal status?

B) Add a diuretic to her treatment regimen to enhance blood pressure control and reduce edema.

A) Increase the dosage of lisinopril to better control her blood pressure.

B) Add a diuretic to her treatment regimen to enhance blood pressure control and reduce edema.

C) Recommend lifestyle modifications and re-evaluate her medication regimen in a month.

D) Initiate patient education on potential side effects of lisinopril, such as hyperkalemia.

A patient with a history of diabetes and hypertension is experiencing signs of heart failure with reduced ejection fraction (HFrEF). The healthcare team is considering adding a loop diuretic to manage fluid overload. What is the nurse's priority assessment to monitor when initiating this medication?

A) Monitoring blood glucose levels

B) Assessing for signs of dehydration

C) Checking for orthostatic hypotension

A patient with a history of hypertension and diabetes presents with signs of fluid overload and orthostatic hypotension. Her current medications include an ACE inhibitor. Which nursing intervention is most appropriate to address her current symptoms and prevent further complications?

A) Educate the patient on reducing sodium intake to help manage fluid retention.

B) Encourage the patient to increase fluid intake to counteract orthostatic hypotension.

C) Instruct the patient to avoid standing up quickly to prevent dizziness and falls.

D) Recommend the patient to stop taking her ACE inhibitor to reduce fluid overload.

diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: In diabetes, insulin deficiency or resistance impairs glucose uptake by cells, leading to elevated blood glucose levels. This results from either autoimmune destruction of pancreatic beta cells (Type 1) or cellular resistance to insulin's effects (Type 2).

• Secondary mechanism: Chronic hyperglycemia causes glycation of proteins and lipids, damaging blood vessels and nerves. This is due to the formation of advanced glycation end-products (AGEs), contributing to microvascular and macrovascular complications.

• Key complication: Persistent high blood glucose levels can lead to diabetic neuropathy, nephropathy, and retinopathy. These complications arise from blood vessel damage, resulting in nerve dysfunction, kidney failure, and vision loss, respectively.

Patient Profile

Demographics:

58-year-old female, retired school teacher

History:

• Key past medical history: Diagnosed with type 2 diabetes 10 years ago, hypertension, hyperlipidemia

• Current medications: Metformin, Lisinopril, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and blurry vision

• Key symptoms: Polyuria, polydipsia, tingling sensation in feet, occasional dizziness

• Vital signs: Blood pressure 150/95 mmHg, heart rate 88 bpm, respiratory rate 18 breaths/min, temperature 98.6 F, blood glucose 210 mg/dL

Section 1

Initial Assessment Findings:

Upon further assessment, the patient's physical examination reveals additional concerning findings. The tingling sensation in her feet, known as peripheral neuropathy, is confirmed with decreased vibratory sensation and diminished ankle reflexes bilaterally. Monofilament testing indicates reduced sensation in the toes and the ball of the foot, suggestive of diabetic neuropathy. Fundoscopic examination reveals microaneurysms and cotton wool spots, indicative of early diabetic retinopathy, which correlates with her complaint of blurry vision. Laboratory tests show an elevated HbA1c level of 8.5%, indicating suboptimal long-term glycemic control. Serum creatinine is mildly elevated at 1.4 mg/dL, with an estimated glomerular filtration rate (eGFR) of 55 mL/min/1.73m², suggesting the onset of diabetic nephropathy.

The patient’s blood pressure remains elevated at 150/95 mmHg despite being on Lisinopril, raising concerns about the adequacy of her current antihypertensive regimen. Her lipid profile shows elevated LDL cholesterol at 140 mg/dL, which, combined with her diabetes and hypertension, places her at increased risk for cardiovascular complications. Given these findings, a multidisciplinary approach is essential to address her complex needs, including optimizing her glycemic control, adjusting her blood pressure and lipid management, and initiating strategies to prevent further progression of diabetic complications.

This initial assessment underscores the importance of comprehensive management to prevent the progression of diabetes-related complications. The next steps in the patient's care will involve revisiting her treatment plan, potentially incorporating additional medications such as a GLP-1 receptor agonist or SGLT2 inhibitor to improve glycemic control and cardiovascular outcomes. Furthermore, a referral to a podiatrist for foot care and an ophthalmologist for regular eye exams will be critical components of her ongoing care to monitor and manage the impacts of diabetic neuropathy and retinopathy. The healthcare team must also educate the patient on lifestyle modifications, including diet, exercise, and smoking cessation, to mitigate her risk factors and improve her overall health outcomes.

Section 2

As the healthcare team implements the revised treatment plan, the patient returns for a follow-up visit six weeks later. During this visit, new diagnostic results reveal some progress and emerging concerns. Her HbA1c has decreased to 7.8%, reflecting an improvement in glycemic control, likely attributed to the addition of an SGLT2 inhibitor to her regimen. However, her blood pressure remains elevated at 148/92 mmHg, prompting a review of her antihypertensive strategy. Additionally, her lipid profile shows a slight improvement with LDL cholesterol now at 130 mg/dL, but still above the target range for a patient with her risk factors.

Clinically, the patient reports adherence to lifestyle modifications, though she admits challenges with consistent exercise due to persisting neuropathic pain in her feet. A repeat monofilament test continues to show decreased sensation, underscoring the need for ongoing podiatric care. Furthermore, a recent ophthalmologist examination shows stable but persistent microaneurysms and cotton wool spots, necessitating regular follow-up to prevent progression to advanced diabetic retinopathy.

In response to these findings, the healthcare team considers adding a calcium channel blocker to her medication regimen to achieve better blood pressure control. Additionally, they emphasize the importance of maintaining lifestyle changes, particularly focusing on weight management and smoking cessation. The team also discusses the potential benefits of a structured exercise program, possibly incorporating low-impact activities to accommodate her neuropathic symptoms. As the patient navigates these adjustments, the team remains vigilant for any signs of new complications, particularly those related to cardiovascular health, given her persistent hypertension and dyslipidemia. The collaborative effort aims to stabilize her condition and prevent further complications, setting the stage for sustained improvement in her health outcomes.

Section 3

As the healthcare team continues to address the patient's complex needs, a new complication arises during her routine follow-up visit. The patient presents with increased fatigue and mild swelling in her lower extremities, prompting a thorough evaluation. Her vital signs reveal a blood pressure of 152/94 mmHg, indicating persistent hypertension despite recent medication adjustments. A physical examination shows mild pitting edema in her ankles and feet, raising concerns about possible fluid retention.

Laboratory tests are conducted to further investigate her condition. Her renal function tests indicate a slight increase in serum creatinine to 1.4 mg/dL, up from her baseline of 1.1 mg/dL, suggesting potential renal impairment. Additionally, her urine analysis reveals trace proteinuria, which is a significant finding given her diabetic status. These results suggest the potential onset of diabetic nephropathy, a complication that necessitates immediate attention to prevent further renal damage.

In response to these developments, the healthcare team discusses the need to optimize her antihypertensive regimen, considering the possible addition of an ACE inhibitor or angiotensin receptor blocker, known for their renal protective effects. They also emphasize the importance of monitoring her renal function closely and adjusting her medications as needed. This new complication highlights the need for ongoing vigilance and a multidisciplinary approach to manage her diabetes and associated comorbidities effectively, setting the course for her next phase of care.

Section 4

As the healthcare team reviews the patient's recent laboratory results, they decide to initiate treatment with an ACE inhibitor, lisinopril, to address both her hypertension and the early signs of diabetic nephropathy. The rationale for this choice is its dual benefit of lowering blood pressure and offering renal protection by reducing proteinuria and slowing the progression of kidney damage. The patient is educated on the importance of adhering to her new medication regimen and is scheduled for follow-up lab tests to monitor her renal function and assess the effectiveness of the intervention.

Over the next few weeks, the patient returns for a follow-up appointment. She reports some improvement in her energy levels and notes a slight reduction in the swelling of her lower extremities. However, her blood pressure remains elevated at 148/92 mmHg, prompting the healthcare team to consider whether her current medication dosage needs adjustment or if additional antihypertensive agents should be incorporated into her treatment plan. Furthermore, her repeat laboratory tests reveal that her serum creatinine has stabilized at 1.3 mg/dL, and her urine shows a slight reduction in proteinuria, indicating a partial positive response to the ACE inhibitor.

Despite these improvements, the team remains vigilant for potential new complications that may arise from her diabetes. They emphasize the importance of regular monitoring and lifestyle modifications, such as dietary changes and increased physical activity, to further support her cardiovascular and renal health. This proactive approach underscores the team's commitment to preventing further complications and ensuring the patient's long-term well-being. As they plan for her next phase of care, they consider incorporating a dietitian and a diabetes educator into her support team to provide a comprehensive care strategy tailored to her evolving needs.

Section 5

As the weeks progress, the patient begins to experience new symptoms that prompt her to return to the clinic for an unscheduled visit. She reports frequent episodes of dizziness and lightheadedness, particularly when standing up quickly. Her family also notes that she seems more fatigued than usual and occasionally feels short of breath during minimal exertion. During the clinical assessment, her blood pressure is measured at 130/84 mmHg while seated, but drops to 108/72 mmHg upon standing, indicating orthostatic hypotension. Her heart rate is slightly elevated at 98 beats per minute, and her respiratory rate is 22 breaths per minute. Additionally, a physical examination reveals mild jugular venous distension and crackles at the lung bases, suggesting fluid overload.

Laboratory investigations are conducted to further assess her condition. Her serum electrolytes reveal a sodium level of 134 mmol/L and a potassium level of 5.1 mmol/L, slightly elevated from previous readings. Her hemoglobin remains stable at 12.5 g/dL, but her B-type natriuretic peptide (BNP) level is elevated at 450 pg/mL, indicating possible cardiac strain. Echocardiography is performed, revealing a reduced ejection fraction of 45%, consistent with heart failure with reduced ejection fraction (HFrEF), a potential complication of diabetes and hypertension.

These findings suggest that while the ACE inhibitor therapy has provided some renal protection and improved proteinuria, the patient is now experiencing signs of heart failure, possibly exacerbated by fluid retention and orthostatic hypotension. The healthcare team recognizes the need to adjust her treatment plan, considering the addition of a loop diuretic to manage fluid overload and possibly a beta-blocker to support cardiac function. They also emphasize the importance of monitoring her blood pressure closely to prevent further cardiovascular complications. This change in patient status requires careful coordination among the healthcare team to ensure a comprehensive approach to her management, addressing both her renal and cardiac health.